Careers
Contact Us

Company
Pipeline
Disease States
Science
Investors

Axsome Therapeutics Initiates MOMENTUM Phase 3 Trial of AXS-07 in Migraine

Posted March 4, 2019 by CognitionDev

filed under: Nasdaq

In the News

Aug 8, 2019

Axsome Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update

Click to view full release

Jul 30, 2019

Axsome Therapeutics To Report Second Quarter 2019 Financial Results On August 8, 2019

Click to view full release

Jul 29, 2019

Axsome Therapeutics Amends Silicon Valley Bank Loan Agreement Increasing Financial Flexibility

Click to view full release

See All News

© 2019 Axsome Therapeutics, Inc. All rights reserved. 200 Broadway, 3rd Floor, New York, NY 10038 info@axsome.com

This modal has no inner div